Non-invasive measurement of cerebral energy status: an opportunity to target neuroprotection in brain injury

ISRCTN ISRCTN84669284
DOI https://doi.org/10.1186/ISRCTN84669284
Secondary identifying numbers 5789
Submission date
12/05/2010
Registration date
12/05/2010
Last edited
12/05/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Martin Smith
Scientific

National Hospital for Neurology & Neurosurgery
Box 30
London
WC1N 3BG
United Kingdom

Study information

Study designSingle centre non-randomised process of care trial
Primary study designObservational
Secondary study designSingle-centre
Study setting(s)Other
Study typeQuality of life
Scientific title
Study acronymNon-invasive measurement of cerebral energy status
Study objectivesWe will use a combination of near infrared spectroscopy systems to assess non-invasively cerebral oxygenation, perfusion and cellular metabolic status in healthy volunteers and critically brain injured adults in order to monitor and quantify cerebral ischaemia in the latter. Specifically we will non-invasively measure changes in cell energy status by monitoring concentration changes in cytochrome oxidase (ox-CCO) using a novel hybrid optical spectroscopy system optimised for the measurement of ox-CCO in adults.
Ethics approval(s)MREC approved (ref: 04/Q0512/67)
Health condition(s) or problem(s) studiedTopic: Neurological; Subtopic: Neurological (all Subtopics); Disease: Nervous system disorders
InterventionVolunteer studies: Hyperoxia, hypoxia, hypercapnea and hypocapnea
Patient studies: NIRS-derived changes in cerebral oxygenation, haemodynamics and oxidised cytochorme c oxidase concentrations, and cerebral microdialysis-derived markers of ischaemia (lactate:pyruvate ratio and glucose).

Study entry: registration only
Intervention typeOther
Primary outcome measureInfrared specotrscopy
Secondary outcome measuresEstimated cerebal oxygen delivery
Overall study start date01/01/2006
Completion date31/12/2011

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target number of participantsPlanned sample size: 170
Key inclusion criteria1. Healthy volunteers and patients with severe traumatic brain injury
2. Male and female, lower age limit of 18 years
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2006
Date of final enrolment31/12/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

National Hospital for Neurology & Neurosurgery
London
WC1N 3BG
United Kingdom

Sponsor information

University College London Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Research and Development Directorate
250 Euston Road
London
NW1 2PG
England
United Kingdom

Website http://www.uclh.nhs.uk/
ROR logo "ROR" https://ror.org/042fqyp44

Funders

Funder type

Research council

Engineering and Physical Sciences Research Council (EPSRC) (UK)
Government organisation / National government
Alternative name(s)
UKRI Engineering and Physical Sciences Research Council, Engineering and Physical Sciences Research Council - UKRI, Engineering & Physical Sciences Research Council, EPSRC
Location
United Kingdom
Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2008 Yes No